Current perspectives on the mechanism of action of artemisinins.

[1]  L. Sibley,et al.  Comparative genomic and phylogenetic analyses of calcium ATPases and calcium-regulated proteins in the apicomplexa. , 2006, Molecular biology and evolution.

[2]  J. Golenser,et al.  Conventional and experimental treatment of cerebral malaria. , 2006, International journal for parasitology.

[3]  S. Krishna,et al.  Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance , 2006, Trends in molecular medicine.

[4]  Caroline Rae,et al.  Immunopathogenesis of cerebral malaria. , 2006, International journal for parasitology.

[5]  Timothy S. Ham,et al.  Production of the antimalarial drug precursor artemisinic acid in engineered yeast , 2006, Nature.

[6]  F. Nosten,et al.  A case-control auditory evaluation of patients treated with artemether-lumefantrine. , 2006, The American journal of tropical medicine and hygiene.

[7]  A. C. Alves,et al.  Malaria Parasites Can Develop Stable Resistance to Artemisinin but Lack Mutations in Candidate Genes atp6 (Encoding the Sarcoplasmic and Endoplasmic Reticulum Ca2+ ATPase), tctp, mdr1, and cg10 , 2006, Antimicrobial Agents and Chemotherapy.

[8]  Eric Legrand,et al.  Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6 , 2005, The Lancet.

[9]  Richard Schlegel,et al.  Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. , 2005, Cancer research.

[10]  S. Ward,et al.  Enantiomeric 1,2,4‐Trioxanes Display Equivalent in vitro Antimalarial Activity Versus Plasmodium falciparum Malaria Parasites: Implications for the Molecular Mechanism of Action of the Artemisinins , 2005, Chembiochem : a European journal of chemical biology.

[11]  B. Meunier,et al.  The antimalarial drug artemisinin alkylates heme in infected mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Wei Li,et al.  Yeast Model Uncovers Dual Roles of Mitochondria in the Action of Artemisinin , 2005, PLoS genetics.

[13]  L. Schofield,et al.  Immunological processes in malaria pathogenesis , 2005, Nature Reviews Immunology.

[14]  D. Ménard,et al.  Association of failures of seven-day courses of artesunate in a non-immune population in Bangui, Central African Republic with decreased sensitivity of Plasmodium falciparum. , 2005, The American journal of tropical medicine and hygiene.

[15]  H. Noedl.  Artemisinin resistance: how can we find it? , 2005, Trends in parasitology.

[16]  P. O’Neill.  The therapeutic potential of semi-synthetic artemisinin and synthetic endoperoxide antimalarial agents , 2005, Expert opinion on investigational drugs.

[17]  D. Fidock,et al.  pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum , 2005, Molecular microbiology.

[18]  K. No,et al.  Three-dimensional structure of Plasmodium falciparum Ca2+ -ATPase(PfATP6) and docking of artemisinin derivatives to PfATP6. , 2005, Bioorganic & medicinal chemistry letters.

[19]  Angus Cameron,et al.  A single amino acid residue can determine the sensitivity of SERCAs to artemisinins , 2005, Nature Structural &Molecular Biology.

[20]  Anders Björkman,et al.  Public health impact of drug resistant Plasmodium falciparum malaria. , 2005, Acta tropica.

[21]  Oliver Burk,et al.  Antimalarial Artemisinin Drugs Induce Cytochrome P450 and MDR1 Expression by Activation of Xenosensors Pregnane X Receptor and Constitutive Androstane Receptor , 2005, Molecular Pharmacology.

[22]  F. Nosten,et al.  Are Transporter Genes Other than the Chloroquine Resistance Locus (pfcrt) and Multidrug Resistance Gene (pfmdr) Associated with Antimalarial Drug Resistance? , 2005, Antimicrobial Agents and Chemotherapy.

[23]  Peter Aldhous,et al.  Counterfeit pharmaceuticals: Murder by medicine , 2005, Nature.

[24]  Virander S. Chauhan,et al.  Reaction of artemisinin with haemoglobin: implications for antimalarial activity. , 2005, The Biochemical journal.

[25]  I. Gaunt,et al.  Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. , 2004, Birth defects research. Part B, Developmental and reproductive toxicology.

[26]  M. Mayxay,et al.  Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross‐sectional survey on the prevalence of fake antimalarials , 2004, Tropical medicine & international health : TM & IH.

[27]  S. Krishna,et al.  Artemisinins: activities and actions. , 2004, Microbes and infection.

[28]  J. Krungkrai.  The multiple roles of the mitochondrion of the malarial parasite , 2004, Parasitology.

[29]  G. Naderi,et al.  Immunosuppressive activity of a molecule isolated from Artemisia annua on DTH responses compared with cyclosporin A. , 2004, International immunopharmacology.

[30]  S. Parapini,et al.  Evidence that haem iron in the malaria parasite is not needed for the antimalarial effects of artemisinin , 2004, FEBS letters.

[31]  M. Claeys,et al.  Characterization of noncovalent complexes of antimalarial agents of the artemisinin-type and Fe(III)-heme by electrospray mass spectrometry and collisional activation tandem mass spectrometry , 2004, Journal of the American Society for Mass Spectrometry.

[32]  S. Toovey,et al.  Response to: artemisinin derivatives: toxic for laboratory animals, safe for humans? , 2004, Toxicology letters.

[33]  S. Krishna,et al.  Artemisinins: mechanisms of action and potential for resistance. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[34]  François Nosten,et al.  Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number , 2004, The Lancet.

[35]  P. Weathers,et al.  Alteration of biomass and artemisinin production in Artemisia annua hairy roots by media sterilization method and sugars , 2004, Plant Cell Reports.

[36]  Narendra Singh,et al.  Artemisinin induces apoptosis in human cancer cells. , 2004, Anticancer research.

[37]  Joanne Egan,et al.  Antimalarial Quinolines and Artemisinin Inhibit Endocytosis in Plasmodium falciparum , 2004, Antimicrobial Agents and Chemotherapy.

[38]  Hui-jun Zhou,et al.  Apoptosis of human umbilical vein endothelial cells induced by artesunate. , 2004, Vascular pharmacology.

[39]  C. D. Fitch.  Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. , 2004, Life sciences.

[40]  T. Gordi,et al.  Artemisinin derivatives: toxic for laboratory animals, safe for humans? , 2004, Toxicology letters.

[41]  A. Serrano,et al.  PLASMODIUM YOELII: IDENTIFICATION AND PARTIAL CHARACTERIZATION OF AN MDR1 GENE IN AN ARTEMISININ-RESISTANT LINE , 2004, The Journal of parasitology.

[42]  Hui-jun Zhou,et al.  Antimalarial dihydroartemisinin also inhibits angiogenesis , 2004, Cancer Chemotherapy and Pharmacology.

[43]  A. Srisarin,et al.  Effect of dihydroartemisinin on the antioxidant capacity of P. falciparum-infected erythrocytes. , 2003, The Southeast Asian journal of tropical medicine and public health.

[44]  Hong Wang,et al.  [Advances in molecular regulation of artemisinin biosynthesis]. , 2003, Sheng wu gong cheng xue bao = Chinese journal of biotechnology.

[45]  A. Gupta,et al.  In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys. , 2003, The Journal of veterinary medical science.

[46]  J. Golenser,et al.  Iron chelators as drugs against malaria pose a potential risk , 2003, Redox report : communications in free radical research.

[47]  C. Riganti,et al.  Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF‐kB activation , 2003, FEBS letters.

[48]  Hui-jun Zhou,et al.  Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro. , 2003, Pharmacological research.

[49]  P. Kremsner,et al.  Angiogenic proteins in brains of patients who died with cerebral malaria , 2003, Journal of Neuroimmunology.

[50]  Prashant V Desai,et al.  Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria. , 2003, Journal of medicinal chemistry.

[51]  S. Krishna,et al.  Artemisinins target the SERCA of Plasmodium falciparum , 2003, Nature.

[52]  S. Meshnick,et al.  Resistance to Antimalarials in Southeast Asia and Genetic Polymorphisms in pfmdr1 , 2003, Antimicrobial Agents and Chemotherapy.

[53]  S. Jain,et al.  Artemisinin, a Novel Antimalarial Drug: Biochemical and Molecular Approaches for Enhanced Production , 2003, Planta medica.

[54]  S. Parapini,et al.  Artemisinin Antimalarials Do Not Inhibit Hemozoin Formation , 2003, Antimicrobial Agents and Chemotherapy.

[55]  A. Cowman,et al.  Analysis of pfcrt, pfmdr1, dhfr, and dhps mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin. , 2003, The American journal of tropical medicine and hygiene.

[56]  L. Dequan,et al.  Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, China. , 2003 .

[57]  M. Tanner,et al.  Schistosoma japonicum: in vitro effects of artemether combined with haemin depend on cultivation media and appraisal of artemether products appearing in the media , 2003, Parasitology Research.

[58]  David A. Fidock,et al.  Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations , 2002, Science.

[59]  N. White,et al.  Neuropathologic toxicity of artemisinin derivatives in a mouse model. , 2002, The American journal of tropical medicine and hygiene.

[60]  Weiliang Zhu,et al.  Molecular docking and 3-D-QSAR studies on the possible antimalarial mechanism of artemisinin analogues. , 2002, Bioorganic & medicinal chemistry.

[61]  W. Charman,et al.  Structure-activity relationships of the antimalarial agent artemisinin. 7. Direct modification of (+)-artemisinin and in vivo antimalarial screening of new, potential preclinical antimalarial candidates. , 2002, Journal of medicinal chemistry.

[62]  G. Schmuck,et al.  Neurotoxic Mode of Action of Artemisinin , 2002, Antimicrobial Agents and Chemotherapy.

[63]  Carlos R Rodrigues,et al.  Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies. , 2002, Journal of medicinal chemistry.

[64]  B. Avery,et al.  Carrier-Mediated Partitioning of Artemisinin into Plasmodium falciparum-Infected Erythrocytes , 2002, Antimicrobial Agents and Chemotherapy.

[65]  N. White,et al.  Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[66]  P. Christen,et al.  New trends in extraction, identification and quantification of artemisinin and its derivatives. , 2001, Current medicinal chemistry.

[67]  M. Bockarie,et al.  Apparent drug failure following artesunate treatment of Plasmodium falciparum malaria in Freetown, Sierra Leone: four case reports. , 2001, Annals of tropical medicine and parasitology.

[68]  G. Bàlint,et al.  Artemisinin and its derivatives: an important new class of antimalarial agents. , 2001, Pharmacology & therapeutics.

[69]  C. Drakeley,et al.  Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. , 2001, The Journal of infectious diseases.

[70]  P. Olliaro,et al.  Possible modes of action of the artemisinin-type compounds. , 2001, Trends in parasitology.

[71]  M. Hoshen,et al.  Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of ‘dormancy’, a partial cytostatic effect of the drug, and its implication for treatment regimens , 2000, Parasitology.

[72]  R. Price,et al.  Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[73]  N. Gogtay,et al.  Probable resistance to parenteral artemether in Plasmodium falciparum: case reports from Mumbai (Bombay), India , 2000, Annals of tropical medicine and parasitology.

[74]  M. Duraisingh,et al.  Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum , 2000, Molecular microbiology.

[75]  K. Kirk,et al.  Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum , 2000, Nature.

[76]  S. Meshnick,et al.  Mechanisms of Artemisinin Resistance in the Rodent Malaria Pathogen Plasmodium yoelii , 2000, Antimicrobial Agents and Chemotherapy.

[77]  W. Quax,et al.  Seasonal Variations of Artemisinin and its Biosynthetic Precursors in Tetraploid Artemisia annua Plants Compared with the Diploid Wild-Type , 1999, Planta medica.

[78]  S. Krungkrai,et al.  Mitochondrial oxygen consumption in asexual and sexual blood stages of the human malarial parasite, Plasmodium falciparum. , 1999, The Southeast Asian journal of tropical medicine and public health.

[79]  H. Pahl.  Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[80]  M. Ashton,et al.  Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. , 1999, British journal of clinical pharmacology.

[81]  T. Brewer,et al.  Acute high dose arteether toxicity in rats. , 1999, Neurotoxicology.

[82]  W. Peters,et al.  The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides. , 1999, Annals of tropical medicine and parasitology.

[83]  T. Eggelte,et al.  Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. , 1999, Trends in pharmacological sciences.

[84]  K. Silamut,et al.  Two patients with falciparum malaria and poor in vivo responses to artesunate. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[85]  L. Bertilsson,et al.  Artemisinin induces omeprazole metabolism in human beings , 1998, Clinical pharmacology and therapeutics.

[86]  J. Dame,et al.  The Plasmodium falciparum Translationally Controlled Tumor Protein Homolog and Its Reaction with the Antimalarial Drug Artemisinin* , 1998, The Journal of Biological Chemistry.

[87]  D. Dufillot,et al.  Light microscopic changes in Plasmodium falciparum from Gabonese children treated with artemether. , 1997, The American journal of tropical medicine and hygiene.

[88]  C. Wongsrichanalai,et al.  In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials. , 1997, Acta tropica.

[89]  M. Avery,et al.  Structure-activity relationships of the antimalarial agent artemisinin. 5. Analogs of 10-deoxoartemisinin substituted at C-3 and C-9. , 1996, Journal of medicinal chemistry.

[90]  R. Price,et al.  Effects of artemisinin derivatives on malaria transmissibility , 1996, The Lancet.

[91]  S. Meshnick,et al.  Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. , 1996, Microbiological reviews.

[92]  P. Phillips-Howard,et al.  The Safety of Antimalarial Drugs in Pregnancy , 1996, Drug safety.

[93]  N. Hunt,et al.  Effects of endotoxin and dexamethasone on cerebral malaria in mice , 1995, Parasitology.

[94]  P. Arese,et al.  A luminescene method for the quantitative determination of phagocytosis of erythrocytes, of malaria‐parasitized eryithrocytes and of malarial pigment , 1994, British journal of haematology.

[95]  Y. Fu,et al.  The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. , 1994, Chinese medical journal.

[96]  W. Milhous,et al.  Structure-activity relationships of the antimalarial agent artemisinin. 1. Synthesis and comparative molecular field analysis of C-9 analogs of artemisinin and 10-deoxoartemisinin. , 1993, Journal of medicinal chemistry.

[97]  S. X. Yang,et al.  Artemisinin and its derivatives enhance T lymphocyte-mediated immune responses in normal mice and accelerate immunoreconstitution of mice with syngeneic bone marrow transplantation. , 1993, Clinical immunology and immunopathology.

[98]  F. T. Ter Kuile,et al.  Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. , 1993, Experimental parasitology.

[99]  F. Liew,et al.  Effects of qinghaosu (artemisinin) and its derivatives on experimental cutaneous leishmaniasis , 1993, Parasitology.

[100]  S. Meshnick,et al.  Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. , 1991, Molecular and biochemical parasitology.

[101]  I. Clark,et al.  Breakdown of the blood-brain barrier in murine cerebral malaria , 1988, Parasitology.

[102]  J. Inselburg.  Induction and isolation of artemisinine-resistant mutants of Plasmodium falciparum. , 1985, The American journal of tropical medicine and hygiene.

[103]  J. B. Jiang,et al.  Qinghaosu-induced changes in the morphology of Plasmodium inui. , 1985, The American journal of tropical medicine and hygiene.

[104]  E. Walker.  Contributions to the Bacteriology of Leprosy. II. The Chromogenic Acid-fast Bacillus of Clegg. , 1923 .

[105]  P. Olliaro,et al.  Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro. , 2006, Reproductive toxicology.

[106]  D. Sullivan,et al.  Bioavailable iron and heme metabolism in Plasmodium falciparum. , 2005, Current topics in microbiology and immunology.

[107]  P. Olliaro,et al.  Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: A review. , 2004, Journal of postgraduate medicine.

[108]  Nirbhay Kumar,et al.  Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu onPlasmodium falciparum , 2004, Parasitology Research.

[109]  W. Wernsdorfer,et al.  Comparative study of the in vitro sensitivity of Plasmodium falciparum to artemisinin in two border areas of Thailand. , 2004, Wiener klinische Wochenschrift.

[110]  D. Kyle,et al.  In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand. , 1999, Bulletin of the World Health Organization.

[111]  P. Olliaro,et al.  Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. , 1998, Medecine tropicale : revue du Corps de sante colonial.

[112]  J. Bras.  In vitro susceptibility of African Plasmodium falciparum isolates to dihydroartemisinin and the risk factors for resistance to qinghaosu. , 1998 .

[113]  T. Eikmann,et al.  Testing of chelating agents and vitamins against lead toxicity using mammalian cell cultures. , 1998, The Analyst.

[114]  D. Warhurst,et al.  Uptake of [3H] dihydroartemisinine by erythrocytes infected with Plasmodium falciparum in vitro. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.